More studies are required to explore the role of Sirt1 in linking AIP to NAFLD in future, which might help reduce the prevalence of NAFLD and initiate early treatment and improving the patient quality of life. The gene discussed is SIRT1; the disease is metabolic dysfunction-associated steatotic liver disease.